{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:31:22Z","timestamp":1792211482624,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.humpath.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:37:18Z","timestamp":1562269038000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma"],"prefix":"10.1016","volume":"91","author":[{"given":"Erika F.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.07.001_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0010","article-title":"Immune checkpoint inhibitors and the development of granulomatous reactions","author":"Cornejo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/DAD.0000000000001066","article-title":"Granulomatous Tumoral melanosis associated with Pembrolizumab therapy: a mimicker of disease progression in metastatic melanoma","volume":"40","author":"Woodbeck","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0020","doi-asserted-by":"crossref","unstructured":"Cappelli LC, Gutierrez AK, Bingham CO, 3rd, Shah AA. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature. Arthritis Care Res (Hoboken) 2017;69: 1751\u20131763.","DOI":"10.1002\/acr.23177"},{"key":"10.1016\/j.humpath.2019.07.001_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JOP.18.00005","article-title":"Management of Immune-Related Adverse Events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline summary","volume":"14","author":"Brahmer","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.humpath.2019.07.001_bb0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/2326-6066.CIR-15-0102","article-title":"Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with Ipilimumab","volume":"3","author":"Tirumani","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.humpath.2019.07.001_bb0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.rmr.2018.08.003","volume":"35","author":"Faviez","year":"2018","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.humpath.2019.07.001_bb0040","doi-asserted-by":"crossref","unstructured":"Lashari BH, Asai M, Randleman G, Sack M, Patel R. Sarcoid-like mediastinal lymphadenopathy in gynecologic malignancy. Pulm Med 2018;2018: 5141575.","DOI":"10.1155\/2018\/5141575"},{"key":"10.1016\/j.humpath.2019.07.001_bb0045","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1200\/JCO.2011.39.3298","article-title":"Pulmonary sarcoid-like granulomatosis induced by ipilimumab","volume":"30","author":"Berthod","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-018-0323-0","article-title":"Granulomatous\/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients","volume":"6","author":"Tetzlaff","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2019.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jtho.2018.04.031","article-title":"Sarcoidosis-like reactions induced by checkpoint inhibitors","volume":"13","author":"Gkiozos","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0060","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cncr.24951","article-title":"Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival","volume":"116","author":"Ku","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2019.07.001_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1470-2045(09)70334-1","article-title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","volume":"11","author":"Wolchok","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"305","author":"Iannuzzi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2019.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-14-0143","article-title":"Pulmonary sarcoid-like granulomatosis after multiple vaccinations of a long-term surviving patient with metastatic melanoma","volume":"2","author":"Bordry","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.humpath.2019.07.001_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/dc.23900","article-title":"Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer","volume":"46","author":"Biswas","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1513\/AnnalsATS.201801-045OC","article-title":"Adequacy of samples obtained by endobronchial ultrasound with Transbronchial needle aspiration for molecular analysis in patients with non-small cell lung Cancer. Systematic review and meta-analysis","volume":"15","author":"Labarca","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.humpath.2019.07.001_bb0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chest.2018.07.017","article-title":"Comparison of programmed death Ligand-1 Immunohistochemical staining between endobronchial ultrasound Transbronchial needle aspiration and resected lung Cancer specimens","volume":"154","author":"Sakata","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2019.07.001_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000480155","article-title":"EBUS-TBNA can distinguish sarcoid-like side effect of Nivolumab treatment from tumor progression in non-small cell lung Cancer","volume":"94","author":"Lainez","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.humpath.2019.07.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160221","article-title":"Adverse events associated with immune checkpoint blockade in patients with Cancer: a systematic review of case reports","volume":"11","author":"Abdel-Wahab","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2019.07.001_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40425-016-0199-9","article-title":"Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature","volume":"4","author":"Reuss","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2019.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.14808","article-title":"Pulmonary sarcoid-like granulomatosis induced by nivolumab","volume":"176","author":"Montaudie","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2016.05.002","article-title":"Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy","volume":"2","author":"Suozzi","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.humpath.2019.07.001_bb0120","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2019.07.001_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1742-6413.64385","article-title":"Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration","volume":"7","author":"Monaco","year":"2010","journal-title":"Cytojournal"},{"key":"10.1016\/j.humpath.2019.07.001_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cncy.21350","article-title":"Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): correlation with adequacy and histologic follow-up","volume":"122","author":"Karunamurthy","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2019.07.001_bb0135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2326-6066.CIR-17-0715","article-title":"Sarcoid-like granulomatosis of the lung related to immune-checkpoint inhibitors: distinct clinical and imaging features of a unique immune-related adverse event","volume":"6","author":"Nishino","year":"2018","journal-title":"Cancer Immunol Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:18Z","timestamp":1758645378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719301200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":27,"alternative-id":["S0046817719301200"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.07.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}